Literature DB >> 31771337

Inpatient Antibiotic Stewardship Interventions in the Adult Oncology and Hematopoietic Stem Cell Transplant Population: A Review of the Literature.

Kelly E Pillinger1, Jeannette Bouchard2, Sarah T Withers3, Krutika Mediwala4, Edoabasi U McGee5, Geneen M Gibson6, Christopher M Bland7, P Brandon Bookstaver2.   

Abstract

Objective: To review the use of antibiotic stewardship interventions in the adult oncology and hematopoietic cell transplantation (HCT) populations. Data Sources: A literature search of PubMed was performed from inception to October 31, 2019. The general search terms used were oncology, cancer, hematologic malignancy, antimicrobial stewardship, antibiotic stewardship, febrile neutropenia, neutropenic fever, de-escalation, discontinuation, prophylaxis, practice guidelines, clinical pathway, rapid diagnostics, Filmarray, Verigene, MALDI-TOF, antibiotic allergy, and antimicrobial resistance. Study Selection and Data Extraction: Relevant English-language studies describing interventions supported by the Infectious Diseases Society of America guidelines on "Implementing an Antibiotic Stewardship Program" were included. Data Synthesis: Antibiotic stewardship publications in the oncology population have increased in recent years. Studies have described the impact of stewardship interventions, including preauthorization, prospective audit and feedback, implementation of clinical pathways, de-escalation of empirical antibiotics for febrile neutropenia (FN) prior to neutrophil recovery, allergy assessments, and use of rapid diagnostic testing. Many of these interventions have been shown to decrease antibiotic use without increased negative consequences, such as affecting length of stay or mortality. Relevance to Patient Care and Clinical Practice: This review synthesizes available evidence for implementing antibiotic stewardship interventions, particularly de-escalation of antibiotics for FN and implementation of clinical pathways for FN and sepsis, in oncology patients and HCT recipients. Summary tables highlight studies and specific research needs for clinicians. Conclusions: Immunocompromised populations, including oncology patients, have often been excluded from stewardship studies. Antibiotic stewardship is effective in reducing antibiotic consumption and improving outcomes in this patient population, although more quality data are needed.

Entities:  

Keywords:  antibiotic resistance; antibiotics; bone marrow transplantation; cancer; clinical pathways; febrile neutropenia; immunosuppression; infectious diseases; oncology

Year:  2019        PMID: 31771337     DOI: 10.1177/1060028019890886

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  5 in total

1.  Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections.

Authors:  Simona Di Giambenedetto; Alberto Borghetti; Lorena Quagliozzi; Valeria Gallucci; Francesca Lombardi; Arturo Ciccullo; Anna Fagotti; Enrica Tamburrini; Giovanni Scambia
Journal:  J Pers Med       Date:  2022-04-18

Review 2.  Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children.

Authors:  Jessica E Morgan; Bob Phillips; Gabrielle M Haeusler; Julia C Chisholm
Journal:  Infect Drug Resist       Date:  2021-03-30       Impact factor: 4.003

Review 3.  Antibiotic Therapy and Gastrointestinal Graft-Versus-Host Disease in the Allogeneic Stem Cell Transplantation Population.

Authors:  Jessica Thomas; Christi Bowe; Joyce E Dains
Journal:  J Adv Pract Oncol       Date:  2022-02-01

4.  Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count-driven approach.

Authors:  Justin G Horowitz; Gerard W Gawrys; Grace C Lee; Brittney A Ramirez; Carole M Elledge; Paul J Shaughnessy
Journal:  Transpl Infect Dis       Date:  2021-07-30

5.  De-implementing low-value care in cancer care delivery: a systematic review.

Authors:  Amir Alishahi Tabriz; Kea Turner; Alecia Clary; Young-Rock Hong; Oliver T Nguyen; Grace Wei; Rebecca B Carlson; Sarah A Birken
Journal:  Implement Sci       Date:  2022-03-12       Impact factor: 7.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.